Financial Summary (All financials)
In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
Revenues | 3,921.7 | 2,052.4 | 1,440.1 | 1,091.4 | 1,052.2 | 434.3 |
Revenue growth | 91.1% | 42.5% | 31.9% | 3.7% | 142.3% | |
Cost of goods sold | 2,958.0 | 1,098.1 | 539.3 | 430.1 | 386.1 | 57.5 |
Gross profit | 963.7 | 954.3 | 900.8 | 661.4 | 666.1 | 376.8 |
Gross margin | 24.6% | 46.5% | 62.6% | 60.6% | 63.3% | 86.8% |
Sales and marketing | 239.3 | 195.9 | 192.8 | 167.2 | 114.1 | 39.5 |
Research and development | 70.3 | 62.6 | 57.4 | 46.7 | 19.4 | |
General and administrative | 338.1 | 349.7 | 334.7 | 222.6 | 166.1 | 25.2 |
EBIT | -23.2 | 318.3 | 322.4 | 319.4 | 474.9 | 178.1 |
EBIT margin | -0.6% | 15.5% | 22.4% | 29.3% | 45.1% | 41.0% |
Pre-tax income | 12.3 | 3,743.3 | 487.8 | 396.0 | 468.5 | 186.5 |
Income taxes | 20.9 | 369.9 | 83.0 | 89.1 | 119.4 | 53.0 |
Tax rate | 169.4% | 9.9% | 17.0% | 22.5% | 25.5% | 28.4% |
Net income | -8.5 | 3,369.5 | 390.9 | 302.7 | 341.0 | 128.9 |
Net margin | -0.2% | 164.2% | 27.1% | 27.7% | 32.4% | 29.7% |
|
Diluted EPS | ($0.03) | $11.09 | $1.29 | $1.08 | $1.35 | |
Shares outstanding (diluted) | 289.9 | 303.9 | 303.3 | 280.9 | 252.8 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|